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Background: In Australia, screening for colorectal cancer (CRC) with colonoscopy is meant to be reserved for people
at increased risk, however, currently there is a mismatch between individuals’ risk of CRC and the type of CRC
screening they receive.
This paper describes the development and optimisation of a Colorectal cancer RISk Prediction tool (‘CRISP’) for use in
primary care. The aim of the CRISP tool is to increase risk-appropriate CRC screening.
Methods: CRISP development was informed by previous experience with developing risk tools for use in primary care
and a systematic review of the evidence. A CRISP prototype was used in simulated consultations by general practitioners
(GPs) with actors as patients. GPs were interviewed to explore their experience of using CRISP, and practice nurses (PNs)
and practice managers (PMs) were interviewed after a demonstration of CRISP. Transcribed interviews and video footage
of the ‘consultations’ were qualitatively analyzed. Themes arising from the data were mapped onto Normalization Process
Theory (NPT).
Results: Fourteen GPs, nine PNs and six PMs were recruited from 12 clinics. Results were described using the four
constructs of NPT: 1) Coherence: Clinicians understood the rationale behind CRISP, particularly since they were familiar
with using risk tools for other conditions; 2) Cognitive participation: GPs welcomed the opportunity CRISP provided to
discuss healthy and unhealthy behaviors with their patients, but many GPs challenged the screening recommendation
generated by CRISP; 3) Collective Action: CRISP disrupted clinician-patient flow if the GP was less comfortable with
computers. GP consultation time was a major implementation barrier and overall consensus was that PNs have more
capacity and time to use CRISP effectively; 4) Reflexive monitoring: Limited systematic monitoring of new interventions
is a potential barrier to the sustainable embedding of CRISP.
Conclusions: CRISP has the potential to improve risk-appropriate CRC screening in primary care but was considered
more likely to be successfully implemented as a nurse-led intervention.
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Australia and New Zealand have the highest rates of
colorectal cancer (CRC) globally, with estimated age
standardized rates of 44.8 and 32.2 per 100,000 in men
and women respectively [1]. Risk-stratified screening is
increasingly recognized as an approach to maximize the
benefits and reduce the potential harms of cancer
screening, especially in the era of personalized/precision
medicine [2]. In Australia, the National Health and
Medical Research Council (NHMRC) guidelines recom-
mend the non-invasive and inexpensive fecal occult
blood test (FOBT), using the fecal immunochemical test
(FIT), for screening in people at average risk of CRC,
and more invasive and expensive colonoscopy only for
those who are at increased risk, with risk-stratification
based on age and family history criteria [3]. However, it
is estimated that for every 1,000,000 Australians aged
50 years and older, 80 000 people at average risk are be-
ing over-screened with colonoscopy, 29 000 at increased
risk are not having the colonoscopy they need [4, 5], and
only 37% participate in the National Bowel Cancer
Screening Program (NBCSP) [6]. Over-screening poten-
tially results in excess costs and excess risks to the
patient due to the invasive nature of colonoscopy, and
under-screening potentially results in missing early-stage
cancer or precancerous lesions.
Risk-stratified screening requires valid risk prediction
models that accurately discriminate people at increased
risk from those who are not. These risk models require
easy-to-use risk assessment tools for implementation
into clinical practice [7]. A recent systematic review of
trials of cancer risk assessment tools in primary care
found that few trials have been conducted with risk tools
in primary care, and of those trials, many have been
limited by methodological flaws including low recruit-
ment rates and a ‘healthy volunteers’ effect [8]. Never-
theless, the review showed that such tools can improve
patient risk perception, cancer knowledge and screening
intentions, although the effect on actual screening
behaviours is less clear. Few risk assessment tools in
these trials implemented validated cancer risk models or
applied the latest evidence on risk communication
methods. Furthermore, several had undergone limited
clinical evaluation prior to testing in a full scale random-
ized controlled trial (RCT), contrary to recommenda-
tions about the development and evaluation of complex
interventions [9, 10].
Our NHMRC funded ‘Centre for Research Excellence
to optimise screening for colorectal cancer’ is undertak-
ing a program of research to develop an Australian CRC
risk prediction model, and to implement it into a risk
assessment tool for use in primary care (‘general prac-
tice’). This paper describes an initial exploratory study
based on the UK’s Medical Research Council Frameworkfor the Development and Evaluation of Complex Inter-
ventions to improve healthcare [9, 10]. This qualitative
Phase I study aimed to examine the useability and ac-
ceptability of a prototype tool ‘CRISP’ (Colorectal cancer
RISk Prediction tool), identify barriers and enablers to
implementing CRISP in Australian general practice, and
optimize the design of CRISP as an important step in
the development of an intervention prior to an efficacy
(Phase II) RCT [10, 11].
Methods
Study participants
We recruited general practices from a broad range of
clinics including some from the Victorian Primary Care
Practice-Based Research Network (VicReN). Practice
managers (PMs) and practice nurses (PNs) were
recruited from the same practices to explore the context
for practice implementation. Participants were reim-
bursed for their time.
CRISP development
The CRISP tool was programmed as Java software lever-
aging the Apache Wicket open source framework for
web application development. This software tool was de-
signed to implement any epidemiological risk model
with simple modifications to data entry fields. Based on
a review of previously validated risk models [12], the
‘Freedman’ CRC risk model (with minor modifications)
was chosen to be the epidemiological model underpin-
ning the prototype CRISP tool [13].
This study used an ‘action design’ method to allow for
changes in CRISP to explore the potential utility of the
different iterations of the tool as respondents’ data were
analyzed.
CRC risk assessment
The CRISP risk assessment tool was designed to assist
clinicians to collect risk information from patients and
provide screening recommendations during a consult-
ation. The CRISP interface was based on the results of
our systematic review of cancer risk assessment tools in
primary care [8] and previous experience in developing
cancer risk tools for use in primary care [14]. Risk
variables captured by CRISP included: age, gender, BMI,
smoking, exercise, diet, previous colonoscopy, previous
polyp, use of non-steroidal anti-inflammatory drugs and
family history and age of onset of CRC, ovarian or endo-
metrial cancer, for first and second degree relatives.
CRISP risk outputs included a recommendation for
the mode of CRC screening based on five-year absolute
CRC risk and a range of visual representations based on
current best evidence about risk communication
research [15–17], including: (see Figures)
Fig. 2 An example of the risk presentation using a graph produced
by the CRISP prototype showing a person’s risk and the background
population risk of CRC over time
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timeframes using percentages and odds (Fig. 1),
2. an icon array demonstrating natural frequencies
of 5-year CRC risk (Fig. 1), and
3. a graph showing individual CRC risks over time
compared to the average population (Fig. 2).
Clinical recommendations
Based on the NHMRC guidelines [3] and five-year abso-
lute CRC risk, CRISP provided four possible clinical rec-
ommendations including: (Fig. 3)
1. no screening for people less than 50 years old with a
five-year absolute CRC risk less than 1.00%;
2. FOBT for people 50 years or older with a five-year
absolute CRC risk less than 1.00%;
3. colonoscopy for people with a five-year absolute
CRC risk greater than or equal to 1.00%; or
4. referral to a familial cancer centre for further risk
assessment for people with a strong family history of
CRC or family history suggestive of Lynch syndrome.
Procedures
GPs were familiarized with CRISP using paper-based
cases and then conducted two simulated consultations
with actors professionally trained to be patients [full de-
scriptions of the case vignettes available in Appendix A].
The actors’ performances were monitored to ensure
standardization. The simulated consultations were con-
ducted in the GPs’ consulting rooms and video recorded.Fig. 1 An example of the risk presentation using percentages, odds and aCRISP was demonstrated and explained to the PNs
and practice managers PMs.
Semi-structured interviews were conducted by the
same interviewer (JGW) after the simulated consulta-
tions or CRISP demonstration. Interviews were audio-
recorded and transcribed.natural frequency icon array produced by the CRISP prototype
Fig. 3 An example of the colorectal cancer screening recommendations produced by CRISP
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Process Theory (NPT). NPT is a well-established socio-
logical theory which proposes a working model for imple-
menting, embedding and sustaining practices and/or
interventions into clinical practice, in particular, in
primary care [18]. Acceptability, usability and implemen-
tation strategies were explored at an individual level (GP,
PN and PM) and organizational level (the practice) using
the four domains of NPT: ‘Coherence’, ‘Cognitive participa-
tion’, ‘Collective action’ and ‘Reflexive monitoring’ [19].
Data saturation was reached when no new themes
were occurring after three consecutive interviews for any
of the three groups.
Analysis
Analysis commenced soon after data collection started.
Video footage of the simulated consultations was ana-
lyzed to explore important non-verbal observations such
as body language of the GP and ‘patient’ and any impact
using CRISP had on doctor-patient interaction. The time
spent per screen and time to complete a CRISP session
as well as any user error were captured electronically.
Video footage and audio transcripts were coded in
dedoose 6.0.24® [20]. A coding framework was developed
inductively involving discussions between the authors
(JGW, JDE, FMW). The themes that arose from the ana-
lysis were then mapped onto the four constructs of
NPT. [19] CRISP was modified during the study in
response to observations and early data analysis. The re-
vised version of CRISP was reviewed by two GPs whohad been previously involved in the study and two GPs
unfamiliar with CRISP.
Ethics approval and consent to participate
All participants were recruited following an informed
consent process involving approved plain language state-




We recruited 14 GPs, nine PNs and six PMs from 12
general practices. The characteristics of the participants
are described in Table 1.
Results of the analysis using the four constructs of NPT
Coherence
‘Coherence’ refers to how the participants make sense
of and value an intervention. Clinic staff agreed CRC
screening was relevant to their practice and were fa-
miliar with using risk assessment tools to support
clinical decision making, particularly for assessing car-
diovascular or diabetes risk, or when screening for
depression.
So we use quite a few assessment tools in the practice
and … obviously find them valuable. So, from that
point of view, we’re not unfamiliar with using them
and certainly wouldn’t be averse to using them across
the board. [PM: 49 years, female]
Table 1 Characteristics of general practitioners, practice nurses
and practice managers participating in the study
Participants Characteristics n (%)a
General practitioners
Age, yearsb 50 (29, 62)
Gender, female 7 (50.0)
Practice location, metropolitan 10 (71.4)
Number of years in general practiceb 22 (1, 34)
Number of GPs working in practice:b
Full-time 2 (0, 7)
Part-time 5 (0, 14)
Hours worked in an average weekb 30 (12, 50)
Postgraduate qualifications, yes 7 (50.0)
More than one qualification 5 (71.4)
Practice nurses
Age, yearsb 55 (48, 68)
Gender, female 9 (100.0)
Practice location, metropolitan 5 (55.6)
Number of years in general practiceb 35 (9, 40)
Hours worked in an average weekb 36 (30, 40)
Specialist qualifications, yes 7 (77.8)
More than one specialization 5 (71.4)
Practice managers
Age, yearsb 50 (29, 58)
Gender, female 6 (100.0)
Practice location, metropolitan 4 (66.7)
Number of years in general practiceb 2 (1, 21)
Hours worked in an average weekb 40 (31, 46)
Specialist qualifications, yes 2 (33.3)
aUnless specified otherwise; bMedian (range)
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emphasize the need to be screened,
…but don’t forget that little person; okay let’s make
sure that’s not you. [GP: 50 years, female]
or to reassure the patient that their risk was low.
…there’s a whole lot of people and this is your chance
out of them of cancer… [GP: 31 years, female]
The graph was more challenging to explain. In the first
iteration of CRISP the y axis (CRC risk) ranged from 0%
to 20% which generated a steep curve at times, and
caused concern that this might mislead patients about
their risk (Fig. 3). All staff preferred the natural fre-
quency icon array to the graph depicting comparative
CRC risk over time.Screening advice was challenged by some GPs who did
not agree with or were not familiar with current
NHMRC guidelines.
…that’s just the tricky bit of saying [to the patient]
that this is what’s [sic] the recommendation but we
don’t always follow what recommendations are…
[GP: 50 years, female]
Many GPs also challenged the necessity for collecting
second degree relative information.
Because once you go beyond that first degree relative,
really the risk diminishes so significantly that getting
all that extra data isn’t going to be that significant.
[GP: 50 years, female]Cognitive participation
‘Cognitive participation’ explores how users engage with
and understand an intervention in the context of their
everyday work. There were specific aspects of CRISP
that everyone liked, including the opportunity to
reinforce healthy behaviours or discuss strategies with
patients for changing unhealthy behaviours (smoking,
diet, and exercise in particular).
Anything that gets people to have a think about their
health is a good thing, anything at all. [PN: 48 years,
female]
The GPs responded easily and almost instinctively to
patients’ responses to these questions.
GP: Do you smoke?Patient: No.GP: Good man! [GP
53 years, male]
On the other hand, there was a general distrust of
some of the recommendations, particularly for FOBT.
Colonoscopy was commonly referred to as the ‘gold
standard’ for CRC screening. GPs were more likely to
recommend colonoscopy if the patient wanted one or
they had previously been recommended one by a gastro-
enterologist, even if the patient was at average risk.Collective action
‘Collective action’ refers to the capacity for the interven-
tion to fit within existing organizational practices. GPs,
PNs and PMs all agreed that lack of GP consultation
time would limit the use of CRISP by GPs. There was a
consensus that nurses have the capacity, time and
expertise to complete the risk assessment as part of
routine preventive health consultations.
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so they could go through these sorts of things… [PM:
48 years, female]
The existing health checks for 45 – 49 year olds [21]
which are funded by the Australian government were
suggested as an optimum time for PNs to introduce
CRISP.
Opinions about who would take responsibility for the
final decision about screening advice was split between
GPs and PNs; many GPs had a fear of missing a diagno-
sis and they often relayed anecdotes of cases of a missed
or late CRC diagnosis.
… I’ve got a 26-year-old patient that has …metastases
everywhere …of course, everybody said it was her
endometriosis… [GP: 50 years, female]
Using CRISP as a self-completed tool in the waiting
room was explored but everyone felt that administrative
staff would not have the time or expertise to manage pa-
tients using CRISP in the waiting room.
…Yeah. I just don’t think it will work in the waiting
room…We might start getting asked questions at the
front desk… That’s the thing, how do we answer? You
know what I mean? [PM: 29 years, female]
Implementation of new interventions into a practice
was generally the GPs’ decision although PMs and PNs
felt they could propose new ideas to the practice.
…the doctors are very open to suggestion. If the
practice nurses, management, or another doctor feels
that this could be a really good idea for the doctors,
it’s taken to the doctors’ meeting and overall feeling of
shall we do this, shall we not is taken place…[PM:
42 years, female]
Despite this, even if a decision was made at a practice
level, GPs still acted independently when incorporating
new technology into their clinical work.
So I’m in a really big group practice… and … people
would be really excited… [But it] would vary because
some people don’t change their practice much at all…
[GP: 33 years, female]
Many GPs found certain aspects of using the CRISP
prototype laborious, especially the method for collecting
family history information.
…this is a labyrinth!… especially having 3 pages for
the 2nd degree relatives…[GP: 50 years, female]GPs wanted CRISP integrated into existing clinical
software so data could be auto-populated and then up-
dated into the patient record but acknowledged that the
variety of software used in different practices would
make it difficult to integrate CRISP universally.
There were challenges using CRISP within a GP con-
sultation. GPs felt uncomfortable taking their attention
away from the patient by looking at the computer.
Despite this, GPs often re-engaged with the patient when
explaining the risk output and screening recommenda-
tions. Younger GPs, particularly those who could touch
type, were able to move more seamlessly between the
computer and the patient. When GPs asked questions of
their patients prior to opening CRISP, which was not
uncommon, they felt the tool was unnecessarily repetitive.
Reflexive monitoring
‘Reflexive monitoring’ refers to how new interventions
are monitored, evaluated and appraised [19]. Clinics
evaluated their practice in an ad hoc way either focusing
attention on a particular ‘disease of the month’, or be-
cause a PN or PM had a special interest in a clinical
condition or in practice management. It was unusual for
a clinic to have regular audits as part of ongoing quality
assurance. Time and poor coding of data were two main
obstacles to evaluating clinical practices.
… the capacity’s there. Yeah, and we certainly have
things that we can do like that, but often we do
nothing. … - it’s like ships in the night, so we can be
here and not even say hi to each other all day
sometimes…[PM: 55 years, female]
Consequently, there were limited systems within the




As a preliminary qualitative study in a program of re-
search to develop and trial a novel CRC risk prediction
tool, we identified clear barriers and facilitators to the
implementation of our prototype tool (CRISP) into
general practice. We found that GPs were capable of
using CRISP in simulated consultations, and were gener-
ally used to applying risk tools as part of their clinical
decision making. Despite this, GPs did not always adhere
to the CRISP screening advice, with many favouring
colonoscopic screening even for people at average risk
as it was considered a ‘better’ screening method. Barriers
to using CRISP included limited consultation time, long-
winded family history collection, and for some GPs, lack
of confidence with computers. All clinic staff thought
the questions about lifestyle were very helpful for
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behaviors and could see how CRISP might fit into a
health-check conducted by the PN. For CRISP to be im-
plemented into practice, it was obvious that it would
need to be more intuitive and shorter and would be eas-
ier if it was integrated into the patient clinical medical
record.
Iterative modifications to the CRISP tool during the study
To increase the useability of CRISP, we reduced the data
entry pages from up to 27 pages to a maximum of eight
pages. Other modifications included:
1. development of an interactive family history collection
page on a single web-page to collect family history;
this was more intuitive and user friendly, and substan-
tially reduced the time to complete CRISP (Fig. 4);
2. modifications to the natural frequency icon array to
include a larger denominator population and
therefore present smaller risks more clearly (Fig. 5);
3. modifications to the graph to reduce potential
overestimation of risk over time (Fig. 6); and
4. as a result of our findings on GPs’ perceptions about
the relative benefits and harms of FOBT and
colonoscopy, we developed additional risk
communication output in CRISP to highlight the
potential harms of colonoscopy and the sensitivity
of FOBT to detect CRC using ‘expected frequency
trees’ (Fig. 7) [16].
Context
Our results are consistent with findings about the few
available cancer risk assessment tools used in primary care
[8]. The use of a dedicated clinician such as a PN has theFig. 4 The revised interactive family history collection page to capture fampotential to increase uptake of the risk tool [22, 23] and,
similar to findings in the Family Healthware Impact Trial,
health promotion within a risk tool increased clinician
‘buy in’ [24]. In comparison with other risk tools, GPs did
not experience a sense of ‘loss of control’ of the consult-
ation when using the tool, even if the screening advice
contradicted their expectations [23, 25].
The CRISP research team previously conducted an
exploratory study of a diagnostic risk assessment tool
(QCancer) using similar methods, but the CRISP study
involved GPs, PNs and PMs. CRISP was more acceptable
to GPs than QCancer, although both were difficult to
introduce into a GP consultation. The advantage of
interviewing all staff in the CRISP study was the discov-
ery that clinic staff were in agreement that CRISP would
be better suited to use in a nurse consultation. Another
significant difference between QCancer and CRISP was
the user interface. A major limitation to the accuracy of
QCancer was input error [25]. This is a common limita-
tion to the accuracy of medical technology in clinical
care [26], but was not found to be a factor in this study.
Perhaps more significantly though was the nature of the
clinical task being supported by the risk assessment tool.
GPs in this study were less confronted by discussing
future risks of colorectal cancer than they were using
the QCancer tool which presented risks of current
undiagnosed cancer for multiple tumour types.
Our study demonstrated that primary care in Australia
has the capacity to implement risk assessment tools
using PNs and potentially contribute to more risk-
appropriate CRC screening. Practice staff felt CRISP
would fit into the context of a preventive health
consultation conducted by a PN, in particular as part
of ‘45 – 49 year old’ health checks already funded byily history of cancer in CRISP
Fig. 5 An example of the revised icon array in the CRISP tool to demonstrate absolute risk of colorectal cancer over 5 years per 1000 people
Fig. 6 An example of the revised graph presented by CRISP to illustrate
absolute risk of colorectal cancer over time relative to the average risk
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chronic diseases [21]. This provides the opportunity
to prime patients to participate in the NBCSP prior
to receiving their NBCSP FOBT after turning 50, and
identify patients at higher risk of CRC for whom
colonoscopy and/or genetic counselling may be indi-
cated. The variety of risk communication formats
employed in the CRISP tool is designed specifically to
support discussion and shared decision making where
there is a choice of screening test and different harms
and benefits to consider. The expected frequency
trees are expected to challenge GPs’ beliefs about the
superiority of colonoscopic screening. Implementing
CRISP as a PN-led intervention has the advantage of
nesting CRISP into an existing model of care, which
frequently involves shared decision making about
disease prevention. This will also minimize the impact
on GPs’ limited consultation time.
Strengths and limitations
Although some of the participants were recruited from a
practice-based research network, we recruited a range of
GPs, PNs and PMs including: 1) rural and metropolitan
practice staff, 2) solo and group practice staff, and 3)
staff from a range of ages and experience level in general
Fig. 7 Expected frequency tree demonstrating the benefits and harms of FOBT and colonoscopy screening for 100 000 patients at average risk
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similar ages, however, this was not atypical for this
population and is likely to be representative [27]. This
applied to PMs as well.
We attempted to recruit GPs, PNs and PMs from the
same clinics, to assess congruency of ideas between staff
at the same clinic. However, this was not always possible
with some clinic staff unavailable for an interview and
one clinic did not have a PN.
Another limitation was the potential for social
desirability bias as participants might not have felt
comfortable criticizing CRISP to the researchers
during the interviews. This was offset by the data
gained from the simulated consultations which have
been demonstrated to predict actual clinical perform-
ance [28].Conclusions
This study has provided important contextual informa-
tion on some of the potential barriers and facilitators to
implementing CRISP and risk-stratified CRC screening
in primary care. It has informed further development of
CRISP so that it is more likely to meet the needs of users
and provide risk information that could support im-
proved screening decision making. We have identified a
preferred model of implementation in practice involving
PNs. This approach will now be tested in an RCT to
assess the effects of implementing CRISP on GP and
patient CRC screening behaviours.Appendix A
Actors’ Vignettes
Case 1:
‘Barry Green’ is attending the clinic for the first time
as a new patient. He has just moved to Melbourne from
interstate and wants to organize to have another colon-
oscopy as he had one a ‘few years ago’ because his
mother had bowel cancer (diagnosed at 58). Barry’s
previous colonoscopy showed no sign of any polyps or
bowel disease.
Barry is a 48 year old male and is 178 cm tall and weighs
80kgs (BMI of 25). He has no current bowel symptoms
and no previous diagnosis of colorectal cancer.
He never uses non-steroidal anti-inflammatories
(NSAIDS), eats vegetables 3 – 4 times per week and
exercises for up to 3 h per week. He doesn’t smoke.
His family history: Mother diagnosed with CRC at
58 years old (deceased).
Unaffected relatives include: father, 1 brother, 1 sister,
2 daughters, 2 paternal aunts, 1 niece, 1 nephew.
Case 2:
‘Glenda Brown’ is an office worker aged 57. She is
170 cm and weighs 80kgs (BMI: 27.7). Glenda has come
to see her GP for a check-up as she has been feeling
tired lately.
She is ‘fairly healthy’ and doesn’t have any obvious
symptoms. She stopped menstruating a couple of
years ago but she has not taken hormone replace-
ment therapy as she has had no problems with
menopause.
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She eats well — including eating vegetables every day
(7 days a week).
When asked about family history: Her brother has
been diagnosed with bowel cancer (aged 54) and her
mother died from bowel cancer as well and she was also
diagnosed in her mid-fifties (55). She has never had a
colonoscopy and not done a Faecal Occult Blood Test
(FOBT) partly because she is a bit worried.
She has smoked cigarettes since she was 25 (15
cigarettes per day) which she has trouble giving up.
She doesn’t take any NSAIDS regularly.
Unaffected relatives include: parents, grandparents,
one sister, one paternal uncle (father’s brother) and
one niece.
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